Page 23 - Labatt BTRC Annual Report 2019-2020
P. 23

  FMG, Luu B, Moriarity BS, Ilkhanizadeh S, Chavez
L, Yu C, Kurian KM, Magnaldo T, Sevenet N, Koch P, Pollard SM, Dirks P, Snyder MP, Largaespada DA,
Cho YJ, Phillips JJ, Swartling FJ, Morrissy AS, Kool M, Pfister SM, Taylor MD, Smith A, Weiss WA. Engineering genetic predisposition in human neuroepithelial stem cells recapitulates medulloblastoma tumorigenesis. Version 2. Cell Stem Cell. 2019 Sep 5; 25(3):433- 446.
Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G. Imaging and diagnostic advances for intracranial meningiomas. Neuro- Oncology. 2019 Jan 14; 21.
Juraschka K, Taylor MD. Medulloblastoma in the
age of molecular subgroups: A review. Journal Neurosurgery Pediatrics. 2019 Oct 1; 24(4):353-363.
Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman
D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U; DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. Journal of Clinical Investigation. 2019 Apr 1; 129(4):1801.
MacLeod G, Bozek DA, Rajakulendran N, Monteiro V, Ahmadi M, Steinhart Z, Kushida MM, Yu H, Coutinho FJ, Cavalli FMG, Restall I, Hao X, Hart T, Luchman HA, Weiss S, Dirks PB, Angers S. Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells. Cell Reports. 2019 Apr 16; 27(3):971-986.
Maslink C, Cheng K, Smith TR, Das S. Advanced age is not a universal predictor of poorer outcome in patients undergoing neurological surgery. World Neurosurgery. 2019 Jun 20.
Merchant TE, Bendel AE, Sabin ND, Burger PC,
Shaw DW, Chang E, Wu S, Zhou T, Eisenstat DD, Foreman NK, Fuller CE, Anderson ET, Hukin J, Lau
CC, Pollack IF, Laningham FH, Lustig RH, Armstrong FD, Handler MH, Williams-Hughes C, Kessel S, Kocak M, Ellison DW, Ramaswamy V. Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. Journal of Clinical Oncology. 2019. 37:974-83.
Nassiri F, Tabatabai G, Aldape K, Zadeh G. Challenges and opportunities in meningiomas: Recommendations from the International Consortium on Meningiomas; Neuro-Oncology. 2019 Jan 14; 21.
Nobre L, Pauck D, Golbourn B, Maue M, Bouffet E, Remke M, Ramaswamy V. Effective and safe tumor inhibition using vinblastine in medulloblastoma. Pediatric Blood & Cancer. 2019; 66.
Oshrine B, Grana N, Moore C, Nguyen J, Crenshaw M, Edwards M, Sudhaman S, Forster VJ, Tabori U. B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency. Blood Advances. 2019; 3(12):1795-8.
Rajakulendran N, Rowland KJ, Selvadurai HJ, Ahmadi M, Park NP, Naumenko S, Dolma S, Ward RJ, So M, Lee L, MacLeod G, Pasiliao C, Brandon C, Clarke ID, Cusimano MD, Bernstein M, Batada N, Angers S, Dirks PB. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells. Genes & Development. 2019 May 1; 33(9- 10):498-510.
Sachdeva R, Wu M, Smiljanic S, Kaskun O, Ghannad- Zadeh K, Celebre A, Isaev K, Morrissy AS, Guan
J, Tong J, Chan J, Wilson TM, Al-Omaishi S, Munoz DG, Dirks PB, Moran MF, Taylor MD, Reimand J, Das S. ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma. Cancer Research. 2019 Aug 15; 79(16):4057-4071.
 23
 














































































   21   22   23   24   25